Aquestive Therapeutics
AQST
AQST
65 hedge funds and large institutions have $102M invested in Aquestive Therapeutics in 2020 Q4 according to their latest regulatory filings, with 15 funds opening new positions, 17 increasing their positions, 21 reducing their positions, and 10 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
more capital invested
Capital invested by funds: $ → $
more funds holding in top 10
Funds holding in top 10: →
2.21% less ownership
Funds ownership: 59.15% → 56.93% (-2.2%)
19% less repeat investments, than reductions
Existing positions increased: 17 | Existing positions reduced: 21
67% less call options, than puts
Call options by funds: $295K | Put options by funds: $898K
Holders
65
Holding in Top 10
2
Calls
$295K
Puts
$898K
Top Buyers
| 1 | +$2.18M | |
| 2 | +$1.45M | |
| 3 | +$348K | |
| 4 |
Squarepoint
New York
|
+$229K |
| 5 |
Bank of New York Mellon
New York
|
+$209K |
Top Sellers
| 1 | -$3.25M | |
| 2 | -$2.16M | |
| 3 | -$1.95M | |
| 4 |
WS
Wedbush Securities
Los Angeles,
California
|
-$501K |
| 5 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
-$488K |